Research on the mechanism of smooth muscle cell gp130 in abdominal aortic aneurysm
Objective To explore the impact of the interleukin-6 cytokine family co-receptor glycoprotein 130(gp130)on vascular smooth muscle cell phenotype and abdominal aortic aneurysm(AAA),identifying potential new targets for AAA prevention and treatment.Methods Smooth muscle cell gp130 knockout was induced by administering tamoxifen[0.1 mg/(g·d)]via intraperitoneal injection to Sm22-ER-Cre+gp130loxP/loxP mice for five consecutive days.A total of 17 eight-week-old smooth muscle-specific gp130 knockout(CKO)and control mice were selected.Both groups underwent combined Pcsk9 adeno-associated virus via tail vein injection(1×1011 v.g.),high-fat feeding,and angiotensin Ⅱ infusion[1 000 ng/(min·kg)for 28 days]to establish a mouse model of AAA.Vascular ultrasound was used to monitor changes in abdominal aortic diameter,with aneurysm formation defined as an increase of more than 50%in maximum outer diameter compared to baseline.EVG staining assessed the rupture of vascular elastic laminae.Real-time quantitative PCR,Western blotting,and immunohistochemistry analyzed the expression of contraction-related and inflammation-related genes.Collagen contraction assays evaluated the contraction function of primary mouse vascular smooth muscle cells.Results Compared to the control group,CKO mice showed a reduced incidence of AAA(P<0.05),decreased vascular diameter(P<0.05),and improved elastic lamina integrity.Expression of contraction-related genes(a-Sma,Sm22,etc.)was upregulated in CKO mice,while inflammation-related genes(Ccl2,Il-6,etc.)were downregulated,accompanied by reduced inflammatory cell infiltration.Isolated primary CKO vascular smooth muscle cells exhibited enhanced contraction function compared to control cells(P<0.05).Conclusions Smooth muscle cell-specific knockout of gp130 protects against the progression of AAA by maintaining smooth muscle cell contraction phenotype and function,as well as alleviating vascular inflammation.